References
- Masi A. T., Rodman G. P., Medsger T. A. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581–90
- Kuwana M., Kaburaki J., Okano Y., Tojo T., Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum 1994; 37: 75–83
- Fanning G. C., Welsh K. I., Bunn C., du Bois R., Black C. M. HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol 1998; 37: 201–7
- Kang S. H., Park M. H., Song E. Y., Kang S. J., Lee E. B., Song Y. W., et al. Association of HLA class II genes with systemic sclerosis in Koreans. J Rheumatol 2001; 28: 1577–83
- Takeuchi F., Nakano K., Yamada H., Hyun Hong G., Nabeta H., Yoshida A., et al. Association of HLA‐DR with progressive systemic sclerosis in Japanese. J Rheumatol 1994; 21: 857–63
- Kuwana M., Kaburaki J., Okano Y., Inoko H., Tsuji K. The HLA‐DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma). J Clin Invest 1993; 92: 1296–301
- Reveille J. D., Durban E., MacLeod‐St Clair M. J., Goldstein R., Moreda R., Altman R. D., et al. Association of amino acid sequence in HLA‐DQB1 first domain with the antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest 1992; 90: 973–80
- Morel P. A., Chang H. J., Wilson J. W., Conte C., Saidman S. L., Bray J. D., et al. Severe systemic sclerosis with anti‐topoisomerase I antibodies is associated with an HLA‐DRw11 allele. Hum Immunol 1994; 40: 101–10
- Tan F. K. Systemic sclerosis: the susceptible host (genetics and environment). Rheum Dis Clin N Am 2003; 29: 211–37
- Kuwana M., Pandey J. P., Silver R. M., Kawakami Y., Kaburaki J. HLA class II alleles in systemic sclerosis patients with anti‐RNA polymerase I/III antibody: associations with subunit reactivities. J Rheumatol 2003; 30: 2392–7
- Arnett F. C., Howard R. F., Tan F. Increased prevalence of systemic sclerosis in a native American tribe in Oklahoma. Association with an Amerindian HLA haplotype. Arthritis Rheum 1996; 39: 1362–70
- Bingnon J. D., Fernandez‐Vina, Cheneau M. L. HLA DNA class II typing by PCR‐SSOP: 12th International Histocompatibility Workshop experience. HLA, vol. 1. Genetic diversity of HLA: functional and medical implications, D Charron. EDK, ParisFrance 1997
- Imanishi T., Akaza T., Kimura A., Tokunaga K., Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. HLA 1991, vol. 1, K Tsuji, M Aizawa, T Sasazuki. Oxford University Press, Oxford 1992; 1065–220
- Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., et al. Crystal structure of the human class II MHC protein HLA‐DR1 complexed with an influenza virus peptide. Nature 1994; 368: 215–21
- Kuwana M., Medsger TA J. r., Wright T. M. T and B cell collaboration is essential for the autoantibody response to DNA topoisomerase I in systemic sclerosis. J Immunol 1995; 155: 2703–14